Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


16.07.2018

3 Arch Virol
2 Clin Infect Dis
1 Infect Immun
5 J Infect Dis
4 J Virol
3 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Pediatr Infect Dis J
3 PLoS One
2 Proc Natl Acad Sci U S A
8 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. SANTOS MR, Assao VS, Santos FAA, Salgado RL, et al
    Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
    Arch Virol. 2018;163:1877-1887.
    PubMed     Text format     Abstract available

  2. WANG X, Dong K, Long M, Lin F, et al
    Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Arch Virol. 2018;163:1851-1861.
    PubMed     Text format     Abstract available

  3. KITAB B, Kohara M, Tsukiyama-Kohara K
    Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Arch Virol. 2018;163:1717-1726.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  4. XU Y, Ye J
    Predicting influenza vaccine effectiveness with hemagglutinin sequences is not sufficient enough.
    Clin Infect Dis. 2018 Jul 9. pii: 5050680. doi: 10.1093.
    PubMed     Text format    

  5. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    PubMed     Text format     Abstract available


    Infect Immun

  6. ATCHESON E, Bauza K, Salman AM, Alves E, et al
    Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors.
    Infect Immun. 2018 Jul 9. pii: IAI.00114-18. doi: 10.1128/IAI.00114.
    PubMed     Text format     Abstract available


    J Infect Dis

  7. HOLBROOK MR
    Will a single-cycle Adenovirus vaccine be effective against Ebola virus?
    J Infect Dis. 2018 Jul 6. pii: 5049709. doi: 10.1093.
    PubMed     Text format    

  8. GAMAGE D, Mach O, Palihawadana P, Zhang Y, et al
    Boosting of mucosal immunity after fractional-dose inactivated poliovirus vaccine.
    J Infect Dis. 2018 Jul 5. pii: 5049361. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. VAN WAGONER N, Fife K, Leone PA, Bernstein DI, et al
    Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-controlled Trial.
    J Infect Dis. 2018 Jul 6. pii: 5049813. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. ANGUIANO-ZARATE SS, Matchett WE, Nehete P, Sastry KJ, et al
    A Replicating Single-cycle Adenovirus Vaccine against Ebola Virus.
    J Infect Dis. 2018 Jul 6. pii: 5049708. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. YOUSAFZAI MT
    Role of fractional dose intradermal inactivated poliovirus vaccine in halting polio transmission: finding the missing piece for global polio eradication.
    J Infect Dis. 2018 Jul 5. pii: 5049362. doi: 10.1093.
    PubMed     Text format    


    J Virol

  12. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    PubMed     Text format     Abstract available

  13. MENACHERY VD, Gralinski LE, Mitchell HD, Dinnon KH 3rd, et al
    Combination attenuation offers strategy for live-attenuated coronavirus vaccines.
    J Virol. 2018 Jul 5. pii: JVI.00710-18. doi: 10.1128/JVI.00710.
    PubMed     Text format     Abstract available

  14. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    PubMed     Text format     Abstract available

  15. MEHTA N, Enwere EK, Dos Santos T, Saffran HA, et al
    Expression of the vaccinia virus anti-apoptotic F1 protein is blocked by PKR in the absence of the viral E3 protein.
    J Virol. 2018 Jul 11. pii: JVI.01167-18. doi: 10.1128/JVI.01167.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  16. DESMET S, Verhaegen J, Van Ranst M, Peetermans W, et al
    Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?
    Lancet Infect Dis. 2018 Jul 9. pii: S1473-3099(18)30346.
    PubMed     Text format    

  17. BARNES GL
    Rotavirus vaccine: a single birth dose?
    Lancet Infect Dis. 2018;18:714-715.
    PubMed     Text format    

  18. IZURIETA P, Breuer T
    Interpretation of the switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10 in Belgium.
    Lancet Infect Dis. 2018 Jul 9. pii: S1473-3099(18)30410.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  19. GURNANI V, Haldar P, Khanal S, Bhatnagar P, et al
    Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.
    MMWR Morb Mortal Wkly Rep. 2018;67:742-746.
    PubMed     Text format     Abstract available


    N Engl J Med

  20. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
    Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    N Engl J Med. 2018;379:138-149.
    PubMed     Text format     Abstract available

  21. VANNICE K, Wilder-Smith A, Hombach J
    Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
    N Engl J Med. 2018 Jul 11. doi: 10.1056/NEJMp1803433.
    PubMed     Text format    


    Pediatr Infect Dis J

  22. GROSSMAN Z, Hadjipanayis A, Degani A, Somekh E, et al
    Tracking Changes in Vaccine Attitudes and Decisions: Results from 2008 and 2016 Parental Surveys.
    Pediatr Infect Dis J. 2018 Jul 11. doi: 10.1097/INF.0000000000002147.
    PubMed     Text format     Abstract available


    PLoS One

  23. ABDUL-CADER MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, et al
    In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
    PLoS One. 2018;13:e0193964.
    PubMed     Text format     Abstract available

  24. MARBAIX S, Peetermans WE, Verhaegen J, Annemans L, et al
    Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.
    PLoS One. 2018;13:e0199427.
    PubMed     Text format     Abstract available

  25. JUNG M
    The effect of maternal decisional authority on children's vaccination in East Asia.
    PLoS One. 2018;13:e0200333.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A


  26. Retraction for Ganesh et al., Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1806429115.
    PubMed     Text format    

  27. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Text format     Abstract available


    Vaccine

  28. HARRISON N, Poeppl W, Miksch M, Machold K, et al
    Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30906.
    PubMed     Text format     Abstract available

  29. HABER M, Lopman BA, Tate JE, Shi M, et al
    A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30923.
    PubMed     Text format     Abstract available

  30. RODRIGUEZ SA, Savas LS, Baumler E, Nyitray AG, et al
    Parental predictors of HPV vaccine initiation among low-income Hispanic females aged 11-17years.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30922.
    PubMed     Text format     Abstract available

  31. FARAG NH, Mansour Z, Torossian L, Said R, et al
    Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30826.
    PubMed     Text format     Abstract available

  32. KURONUMA K, Honda H, Mikami T, Saito A, et al
    Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30903.
    PubMed     Text format     Abstract available

  33. PAIGE LAKE BA, Kasting ML, Malo T, Giuliano AR, et al
    An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30924.
    PubMed     Text format     Abstract available

  34. RAILEY AF, Lembo T, Palmer GH, Shirima GM, et al
    Spatial and temporal risk as drivers for adoption of foot and mouth disease vaccination.
    Vaccine. 2018 Jul 6. pii: S0264-410X(18)30910.
    PubMed     Text format     Abstract available

  35. APAYDIN KZ, Fontenot HB, Borba CPC, Shtasel DL, et al
    Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30898.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: